-
S26 - Scientific symposium sponsored by Novo Nordisk - Beyond Metabolic Control: Incretin Mimetics as Gamechangers in Cardiometabolic Inflammation and CV Risk
Done
-
S16 - Scientific symposium sponsored by MSD - Next-Gen Therapies in Cardiology: from Sotatercept to the Future of Lipid Management
Done
-
S22 - Scientific symposium sponsored by Bayer: Beyonttra: A new chapter in ATTR-CM management
Done
-
S7 - Scientific symposium sponsored by AstraZeneca:Belgian Initiatives in Cardiovascular Care to improve the Journey of Patients with Heart Failure, Hypertension, and Cardiac Amyloidosis
Done
-
S13 - Scientific symposium sponsored by BMS - Cardiovascular care and prevention through an economic lens: optimizing oHCM via early search, detection, treatment, and structured care
Done
-
S19 - Scientific symposium sponsored by Eli Lilly - Tirzepatide and the Cardiologist: A New Chapter in Cardiometabolic Risk Management
Done
-
S29 - BWGNICI - Imaging in inflammatory myopericardial syndrome: update from the 2025 Guidelines
Done
-
S2 - Radiation
Done
-
S11 - Nursing 4 - Beyond Boundaries: Transmural and Interprofessional Pathways in Chronic Cardiac Management
Done
-
S15 - BWGHF - Heart Failure in Women
Done
13:50 - 13:55, Welcome and presentation
Antoine Bondue - Erasme HUB
Philippe Debonnaire (MD, PhD, FESC) is cardiologist at Sint-Jan Hospital Bruges, focusing on diagnostic and therapeutic advanced echocardiographic imaging applications, including structural heart disease and interventions. Additionally, he has developed expertise in cardiac amyloidosis, with active scientific publications (h-index 30) and (inter)national lectures. Dr Debonnaire is immediate BWGNICI past-president and current EACVI Scientific Initiatives Committee member. He leads the echocardiographic imaging fellowship program in his centre.

14:15 - 14:35, The treatment
Prof. Dr. Antoine Bondue is Head of the Cardiology Department at HUB Erasme Hospital in Brussels, President of the Belgian Cardiac League, and President of the Belgian Council of Cardiovascular Genomics. He is a member of the European Society of Cardiology (ESC) and a member of the European Council of Cardiovascular Genomics. Professor Bondue specializes in cardiomyopathies, cardiac amyloidosis, inherited cardiac conditions, and neurodegenerative diseases.

Olivier Lairez holds a position of professor at the University of Toulouse, France. He has both specialities of cardiologist and nuclear physician, which he practises at the Toulouse University Hospital, France.
He heads the cardiac imaging centre and the reference centre for cardiomyopathies and cardiac amyloidosis.
His research interests are focused on cardiomyopathies and cardiac aging leading to heart failure.

14:55 - 15:05, Q&A led by Prof. Antoine Bondue